Study will examine PhytoSERM, a natural approach to menopausal hot flashes, developed at the university.

Researchers investigating Alzheimer’s disease are focusing on the hormone estrogen.

Allopregnanolone is showing promise as a treatment for Alzheimer’s disease in elderly people and conditions including cerebral palsy in premature infants.

A University of Arizona Health Sciences study discovered the role of disrupted brain lipid metabolism in the onset and progression of Alzheimer’s disease.

Researchers in the UArizona Health Sciences Center for Innovation in Brain Science are investigating a drug that has the potential to reduce inflammation and increase the regeneration of nerve cells in people with ALS or Lou Gehrig’s disease.

A new study out of the UArizona Center for Innovation in Brain Science found that anti-hyperglycemic medications used to treat Type 2 diabetes resulted in an increased risk of multiple sclerosis for people older than 45, particularly among women.

Dr. Roberta Brinton, director of the Center for Innovation in Brain Science and Aqualung Therapeutics Corp., to receive AZBio awards..

Dr. Roberta Diaz Brinton, an internationally renowned researcher at the University of Arizona Health Sciences, will be honored during Arizona Bioscience Week.

Six women from the UArizona Health Sciences will receive Women of Impact Awards on Wednesday, Aug. 24, in the forum of the Health Sciences Innovation Building.

30 Women in the area of research and innovation have been elected as part of the inaugural class of the UArizona Women of Impact. Out of these 30, 8 are BIO5 members, yet all of the elected women are laying the groundwork for a brighter future.

Researchers at the Center for Innovation in Brain Science received a MERIT award to continue studying the effects of estrogen on the brain during aging.

A $2.7 million MERIT award will allow UArizona researchers to continue studying menopause, an aging transition unique to women that may affect the bioenergetic capacity in the brain.

A UArizona study finds Alzheimer’s gene can influence metabolic changes and override sex-specific differences.

A $7.6 million grant from the NIH is funding a clinical trial to allow researchers at UArizona to test a plant-based alternative to hormone therapy.

Researchers in the UArizona Health Sciences Center for Innovation in Brain Science are investigating an oral drug candidate that may benefit patients with Lou Gehrig’s disease.

Three UArizona founded and commercialized bioscience startups accepted to Flinn Foundation Entrepreneurship Program. Tech Launch Arizona helped these companies through various processes to help each startup team strategize for the future and prepare for t

Seven Arizona bioscience startups will receive $30,000 and other help as the latest participants in the Flinn Foundation Bioscience Entrepreneurship Program.